Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
APOBEC3B is a member of the cytidine deaminase gene family. Additionally we are shipping APOBEC3B Proteins (4) and many more products for this protein.
Showing 10 out of 57 products:
Human Polyclonal APOBEC3B Primary Antibody for WB - ABIN5572734
Yan, He, Gao, Wu, Li, Huang, Liang, Wu, Li: Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study. in Journal of Cancer 2016
These studies combine to indicate that APOBEC3B promotes drug resistance in breast cancer and that inhibiting APOBEC3B-dependent tumor evolvability may be an effective strategy to improve efficacies of targeted cancer therapies.
Our results provide evidence that APOBEC3B can interact with HBV core protein and edit HBV DNAs during reverse transcription. These data suggest that APOBEC3B exerts multifaceted antiviral effects against HBV.
review of current understanding of APOBEC3A (show APOBEC3A Antibodies) and APOBEC3B biology in human papillomavirus Infection restriction, evolution, and associated cancer mutagenesis
This study found that A3B (show SGCB Antibodies) C-terminal domain shows higher activity toward its target sequence in short ssDNA and efficiently deaminates a target sequence located near the center of ssDNA.
Data show that the larger oligomeric state of APOBEC3B (A3B (show SGCB Antibodies)) inhibited its activity.
APOBEC3B*c.783delG showed evidence of modest association with breast cancer and seemed to contribute to earlier onset of the disease.
Data show that APOBEC3B (A3B (show SGCB Antibodies)) expression is inversely related to p53 (show TP53 Antibodies) status in different cancer types and demonstrate that this is due to a direct and pivotal role for p53 (show TP53 Antibodies) in repressing A3B (show SGCB Antibodies) expression.
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation have been reported.
A lysine-free derivative of human APOBEC3B was constructed and shown to be indistinguishable from the wild-type enzyme in DNA cytosine deamination, HIV-1 restriction, and nuclear localization activities.
exposures to relevant environmental factors might induce APOBEC3A (show APOBEC3A Antibodies) or APOBEC3B expression above genotoxic levels and initiate tumorigenesis in a tissue-specific manner in the right cellular environment where ssDNA is available
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. A hybrid gene results from the deletion of approximately 29.5 kb of sequence between this gene, APOBEC3B, and the adjacent gene APOBEC3A. The breakpoints of the deletion are within the two genes, so the deletion allele is predicted to have the promoter and coding region of APOBEC3A, but the 3' UTR of APOBEC3B. Two transcript variants encoding different isoforms have been found for this gene.
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
, probable DNA dC->dU-editing enzyme APOBEC-3B
, apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3B
, DNA dC->dU-editing enzyme APOBEC-3B
, cytidine deaminase
, phorbolin 2
, phorbolin 3
, phorbolin-1-related protein
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
, DNA dC->dU-editing enzyme APOBEC3
, apolipoprotein B editing complex 3
, probable DNA dC->dU-editing enzyme APOBEC3